Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a buddy system ease the burden of a rare lung disease?

NCT ID NCT06811389

First seen May 31, 2026 · Last updated Jun 23, 2026 · Updated 5 times

Summary

This study tests a 10-week program called RISE-HP for people with hypersensitivity pneumonitis (HP), a lung condition that can cause anxiety, depression, and poor quality of life. Participants work one-on-one with a trained peer coach (someone who also has HP) to learn coping skills and get disease education. The goal is to see if this approach is practical and helps people feel better. The study compares RISE-HP to a general health education program and will enroll 42 adults in the U.S.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERSENSITIVITY PNEUMONITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Weill Cornell Medicine

    RECRUITING

    New York, New York, 10065, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

behavioral intervention (peer coaching with cognitive behavioral therapy and education)

What this could lead to

If it works, this could provide a new way to help people with hypersensitivity pneumonitis feel better day-to-day and manage their condition more effectively.

What could go wrong

This is a small, early feasibility study (42 people) testing a behavioral program, not a drug. It may not show clear benefits, and results may not apply to everyone with HP.

Conditions

The condition(s) this trial relates to.

hypersensitivity pneumonitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.